Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Pfizer”

A Study to Learn if the Study Medicine Called Itraconazole and if Food Changes How the Body Processes the Other Study Medicine Called PF 07258669 in Older Adults or Healthy AdultsCompleted
NCT06706869Phase 1Updated Aug 3, 2025
Sponsor: Pfizer
Healthy
United States
A Study to Learn if the Study Medicines Called Itraconazole and Cyclosporine Change How the Body Processes the Other Study Medicine Called Danuglipron in Healthy Adults.Completed
NCT06541678Phase 1Updated Aug 3, 2025
Sponsor: Pfizer
Healthy
United States
Parametric Cardiac 18F-flutemetamol PET Imaging in ATTR CardiomyopathyCompleted
NCT05374564Phase 1Updated Aug 3, 2025
Sponsor: Yale University
Cardiomyopathies, Primary
United States
A Study to Understand How Effective is Tofacitinib When Compared to Other Advanced Treatments in Patients With Rheumatoid ArthritisCompleted
NCT06418529N/AUpdated Jul 31, 2025
Sponsor: Pfizer
Rheumatoid Arthritis
United States
A Study to Learn About the Effects of Multiple Doses of Sisunatovir on People With Respiratory Syncytial Virus (RSV) InfectionCompleted
NCT03258502Phase 2Updated Jul 31, 2025
Sponsor: Pfizer
Respiratory Syncytial Virus Infections
United Kingdom
A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)Completed
NCT02684006Phase 3Updated Jul 30, 2025
Sponsor: Pfizer
Renal Cell Cancer
United States, Australia, Austria, Belgium, Canada +16 more
Pfizer-BioNTech COVID-19 Vaccine Effectiveness Study - Kaiser Permanente Southern CaliforniaCompleted
NCT04848584N/AUpdated Jul 29, 2025
Sponsor: Pfizer
COVID-19
United States
A Study to Understand How the Use of Paxlovid Affected Healthcare Use in People With Pre-existing Conditions.Completed
NCT07090486N/AUpdated Jul 29, 2025
Sponsor: Pfizer
COVID-19
United States
A Clinical Research Study to Determine Whether PD 0332991 May Be Effective in Treating Patients With Liver CancerCompleted
NCT01356628Phase 2Updated Jul 28, 2025
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Advanced Hepatocellular Carcinoma · HCC · Liver Cancer
United States
ProTarget - A Danish Nationwide Clinical Trial on Targeted Cancer Treatment Based on Genomic ProfilingRecruiting
NCT04341181Phase 2Updated Jul 25, 2025
Sponsor: Ulrik Lassen
Cancer · Tumors · Neoplasms · Neoplasia
Denmark
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of Combined Modified RNA Vaccine Candidates Against COVID-19 and InfluenzaCompleted
NCT05596734Phase 2Updated Jul 23, 2025
Sponsor: BioNTech SE
Influenza, Human · COVID-19
United States
HER2 and LA/mUC: A Multi-country Chart Review Cohort StudyCompleted
NCT05902494N/AUpdated Jul 20, 2025
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Urothelial Carcinoma
United States, Austria, France, Germany
Ritlecitinib in CTCLTerminated
NCT05879458Phase 2Updated Jul 18, 2025
Sponsor: Icahn School of Medicine at Mount Sinai
CTCL · Mycosis Fungoides · Sezary Syndrome
United States
A Study to Learn How Different Amounts of the Study Medicine Called PF-07941944 Are Tolerated in the Body of Healthy Adults.Completed
NCT06920498Phase 1Updated Jul 17, 2025
Sponsor: Pfizer
Healthy Participants
Belgium
Rimegepant in Moderate Plaque-type PsoriasisCompleted
NCT04629950Phase 2Updated Jul 17, 2025
Sponsor: Weill Medical College of Cornell University
Psoriasis
United States
EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe DiseaseRecruiting
NCT05261139Phase 3Updated Jul 17, 2025
Sponsor: Pfizer
COVID-19
United States, Bulgaria, Japan, Mexico, Puerto Rico +2 more
Treatment Patterns And Outcomes In Patients Treated With Benefix Or Refacto/Refacto AF - A Swedish Cohort StudyCompleted
NCT02740413N/AUpdated Jul 16, 2025
Sponsor: Pfizer
Hemophilia A · Hemophilia B
BeneFIX Drug Use Results Survey [All-Case Surveillance]Completed
NCT01154231N/AUpdated Jul 16, 2025
Sponsor: Pfizer
Hemophilia B
Japan
Post-Marketing Surveillance Study To Observe INLYTA® Treatment Dosing Pattern, Safety And Effectiveness In Taiwan Real World Routine PracticeCompleted
NCT02533258N/AUpdated Jul 16, 2025
Sponsor: Pfizer
Renal Cell Carcinoma
Nivolumab Plus Axitinib in Patients With Anti-PD1 Refractory Advanced MelanomaCompleted
NCT04493203Phase 2Updated Jul 15, 2025
Sponsor: Yana Najjar
Advanced Melanoma · Unresectable Melanoma
United States
Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative ColitisCompleted
NCT04607837Phase 2Updated Jul 15, 2025
Sponsor: Pfizer
Ulcerative Colitis
United States, Australia, Belarus, Belgium, Bulgaria +13 more
Special Investigation for Booster Dose of Comirnaty in Children Ages 6 Months Though 4 YearsCompleted
NCT06130410N/AUpdated Jul 14, 2025
Sponsor: Pfizer
SARS-CoV-2 · COVID-19
Japan
PLACEBO-CONTROLLED SAFETY STUDY OF RITLECITINIB (PF-06651600) IN ADULTS WITH ALOPECIA AREATATerminated
NCT04517864Phase 2Updated Jul 11, 2025
Sponsor: Pfizer
Alopecia Areata
United States, Australia, Canada, Poland
Use of Individual Pharmacokinetically (PK)-Guided Sunitinib Dosing: A Feasibility Study in Patients With Advanced Solid TumorsCompleted
NCT01286896Phase 1Updated Jul 10, 2025
Sponsor: The Netherlands Cancer Institute
Malignant Solid Tumour
Netherlands
EPIC-HR: Study of Oral PF-07321332/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19Completed
NCT04960202Phase 2, Phase 3Updated Jul 10, 2025
Sponsor: Pfizer
COVID-19
United States, Argentina, Brazil, Bulgaria, Colombia +15 more

Previous page Next page